468
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia

ORCID Icon, , , , &
Pages 1187-1192 | Received 21 Jun 2018, Accepted 25 Aug 2018, Published online: 15 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

YeeAnn Chen, Kaitlyn Buhlinger, Anthony J. Perissinotti, Allison J. Schepers, Lydia Benitez, Jessica Auten, Sheh-Li Chen, Dale L. Bixby, Patrick W. Burke, Kristen M. Pettit & Bernard L. Marini. (2022) Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase. Leukemia & Lymphoma 63:11, pages 2663-2670.
Read now
Craig W. Freyer, Alison Carulli, Alex Ganetsky, Mitchell E. Hughes, Tracy M. Krause, Colleen Timlin, Noelle V. Frey, Saar I. Gill, Elizabeth O. Hexner, Alison W. Loren, James K. Mangan, Mary Ellen Martin, Shannon R. McCurdy, Alexander E. Perl, Keith Pratz, David L. Porter & Selina M. Luger. (2020) Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & Lymphoma 61:9, pages 2200-2207.
Read now
Thomas Sau-Yan Chan, Yu Yan Hwang & Eric Tse. (2020) Risk assessment of venous thromboembolism in hematological cancer patients: a review. Expert Review of Hematology 13:5, pages 471-480.
Read now

Articles from other publishers (12)

Jack T. Seki, Reem Alsibai, Eshetu G. Atenafu, Ruiqi Chen & Hassan Sibai. (2023) Is native E coli- or Peg-ASP more thrombogenic in adult ALL? A systematic review and meta-analysis. Thrombosis Update 12, pages 100143.
Crossref
Hoda Pourhassan, Dan Douer, Vinod Pullarkat & Ibrahim Aldoss. (2022) Asparaginase: How to Better Manage Toxicities in Adults. Current Oncology Reports 25:1, pages 51-61.
Crossref
Ibrahim Aldoss, Hoda Pourhassan & Dan Douer. (2022) SOHO State of the Art Updates and Next Questions | Asparaginase—Understanding and Overcoming Toxicities in Adults with ALL. Clinical Lymphoma Myeloma and Leukemia 22:11, pages 787-794.
Crossref
Dan Douer, Nicola Gökbuget, Wendy Stock & Nicolas Boissel. (2022) Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia. Blood Reviews 53, pages 100908.
Crossref
Ibrahim Aldoss & Dan Douer. (2021) Asparaginase: Understanding and Overcoming Toxicities. Clinical Lymphoma Myeloma and Leukemia 21, pages S90-S94.
Crossref
David O. Riley, Jenna M. Schlefman, Hans Christoph Vitzthum Von Eckstaedt V, Amy L. Morris, Michael K. Keng & Firas El Chaer. (2021) Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit. Current Hematologic Malignancy Reports 16:3, pages 314-324.
Crossref
Sarah M. Kashanian, Noa G. Holtzman, Ciera L. Patzke, Jonathan Cornu, Alison Duffy, Madhurima Koka, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Jummai Apata, Farin Kamangar & Ashkan Emadi. (2021) Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer Chemotherapy and Pharmacology 87:6, pages 817-826.
Crossref
Cecilie U Rank, Line Stensig Lynggaard, Bodil Als-Nielsen, Wendy Stock, Nina Toft, Ove Juul Nielsen, Thomas Leth Frandsen, Ruta Tuckuviene & Kjeld Schmiegelow. (2020) Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Joselle Cook & Mark Litzow. (2020) Advances in Supportive Care for Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 15:4, pages 276-293.
Crossref
J. Fulcher & M. Carrier. (2020) Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches?. Thrombosis Research 188, pages 100-102.
Crossref
Jeffrey I. Zwicker, Tzu‐Fei Wang, Daniel J. DeAngelo, Mandy N. Lauw, Jean M. Connors, Anna Falanga, Malgorzata McMasters & Marc Carrier. (2020) The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis 18:2, pages 278-284.
Crossref
Jennifer Young, Jaclyn Sawyer, Meredith Jenkins, Maureen O'Brien, Lori Luchtman‐Jones & Erin H. Breese. (2019) Capped antithrombin III dosing is cost effective in the management of asparaginase‐associated thrombosis. Pediatric Blood & Cancer 66:6, pages e27719.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.